Serum Lactate as a marker for severity at diagnosis of Sepsis
Not Applicable
- Conditions
- Health Condition 1: A419- Sepsis, unspecified organism
- Registration Number
- CTRI/2020/01/022823
- Lead Sponsor
- Department of General Medicine Manipal Hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients admitted with suspected sepsis
Patients aged more than 18 years
Exclusion Criteria
Pregnant/ Lactating Women
Patients receiving treatment with Metformin/ Antiretroviral Therapy/ Antitubercular therapy/ Valproic Acid/ Ethylene Glycol poisoning , as these patients would have confounding increase in serum lactate levels independent of sepsis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All- Cause Mortality <br/ ><br>Number of Days of ICU stay/ Hospital Stay <br/ ><br>Requirement of Ventilator Support/ Renal Replacement Therapy <br/ ><br>Prolonged ICU stay/ Hospital Stay described as more than 7 <br/ ><br>dayTimepoint: 3 days: For Change in SOFA <br/ ><br>7 days: As an indicator of Prolonged ICU Stay/ Hospital Stay <br/ ><br>Status at 30 days/ At discharge: As an indicator for Outcome <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. Number of Days of ICU stay/ Hospital Stay <br/ ><br>2. Requiring Ventilator Support/ Renal Replacement Therapy <br/ ><br>3. Prolonged ICU stay/ Hospital Stay described as more than 7 daysTimepoint: 30 days/ At discharge